Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study

Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study

Background/Aims Long-term use of aspirin can be a risk factor of peptic ulcer diseases. The aim of this study was to evaluate the efficacy of Albis (Daewoong Pharmaceutical Co., Ltd.) for the prevention of gastric mucosal injury caused by aspirin. Methods Aspirin users were enrolled and randomized i...

Full description

Bibliographic Details
Main Authors: Sang Gyun Kim, Nayoung Kim, Sung Kwan Shin, In Kyung Sung, Su Jin Hong, Hyo-Jin Park
Format: Article
Language:English
Published: Korean Society of Gastrointestinal Endoscopy 2017-03-01
Series:Clinical Endoscopy
Subjects:
Peptic ulcer
Aspirin
Albis
Modified Lanza score
Online Access:http://www.e-ce.org/upload/pdf/ce-2016-031.pdf

Internet

http://www.e-ce.org/upload/pdf/ce-2016-031.pdf

Similar Items